<DOC>
	<DOCNO>NCT01208090</DOCNO>
	<brief_summary>This study ass efficacy , safety tolerability two dos ACT 128800 patient moderate-to-severe chronic plaque psoriasis .</brief_summary>
	<brief_title>ACT-128800 Patients With Moderate Severe Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Adult male female age 18 60 year ( inclusive ) moderate severe chronic plaque psoriasis require systemic treatment . Patients forms psoriasis patient currently treat autoimmune disorder psoriasis . Systemic topical treatment psoriasis emollient . Ongoing bacterial , viral fungal infection . History presence malignancy . Additional inclusion exclusion criterion apply respect medical condition concomitant treatment could affect patient ' risk participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>chronic plaque psoriasis</keyword>
	<keyword>Moderate severe chronic plaque psoriasis</keyword>
</DOC>